Sucampo Receives $15 Million Milestone Payment from Abbott on First Sale of AMITIZA® (lubiprostone) in Japan

Sucampo Receives $15 Million Milestone Payment from Abbott on First Sale of AMITIZA® (lubiprostone) in Japan

[Business Wire] – BETHESDA, Md. & TOKYO–(BUSINESSWIRE)– Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) (SPI) today announced that its subsidiary, Sucampo AG, has received a $15 million milestone payment from Abbott’s (NYSE: … more

View todays social media effects on SCMP

View the latest stocks trending across Twitter. Click to view dashboard

See who Sucampo is hiring next, click here to view

Share this post